Lewy Body Dementia
27
7
10
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
7.4%
2 terminated out of 27 trials
83.3%
-3.2% vs benchmark
7%
2 trials in Phase 3/4
40%
4 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 10 completed trials
Clinical Trials (27)
A Study of Caregiver Connections Via Technology in Dementia
Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
North American Prodromal Synucleinopathy Consortium Stage 2
PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
Retinal Imaging in Neurodegenerative Disease
Anti-Diabetic Medications to Fight PD and LBD
tDCS Effect on Psychotic Symptoms in Dementia With Lewy Bodies (DLB), and Impacts on Caregiver Burden
Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)
hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases
Pulsed Electromagnetic Field Treatment With Dementia Patients
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones
Telehealth-enabled Integrated Palliative Care for People With Dementia
Exergaming Revolution in Dementia
Safety and Efficacy of AR1005 in Patients with Lewy Body Disease
Innovations in Dementia Empowerment and Action
Environmental and Reproductive Health Risk for Lewy Body Dementia
Advances in Telephone-based Cognitive Screening Procedures
A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia
Non-invasive Transcranial Focused Low-intensity Ultrasound Stimulation in Patients With Mild Lewy Body Dementia